A citation-based method for searching scientific literature

Oluwadamilola M Fayanju, Yi Ren, Samantha M Thomas, Rachel A Greenup, Jennifer K Plichta, Laura H Rosenberger, Nina Tamirisa, Jeremy Force, Judy C Boughey, Terry Hyslop, E Shelley Hwang. Ann Surg 2018
Times Cited: 71



W Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Mei Liu, Andrew Walls, Alex Bousamra, Maheshwari Ramineni, Bruno Sinn, Kelly Hunt, Thomas A Buchholz, Vicente Valero, Aman U Buzdar, Wei Yang, Abenaa M Brewster, Stacy Moulder, Lajos Pusztai, Christos Hatzis, Gabriel N Hortobagyi. J Clin Oncol 2017
Times Cited: 280




List of shared articles



Times cited

Pathologic response as predictor of recurrence, metastasis, and survival in breast cancer patients receiving neoadjuvant chemotherapy and total mastectomy.
Jiaqiang Zhang, Mingyang Sun, Enqiang Chang, Chang-Yun Lu, Ho-Min Chen, Szu-Yuan Wu. Am J Cancer Res 2020
10

Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy.
Shin-Cheh Chen, Chi-Chang Yu, Hsien-Kun Chang, Yung-Chang Lin, Yung-Feng Lo, Shih-Che Shen, Wen-Lin Kuo, Hsiu-Pei Tsai, Hsu-Huan Chou, Chia-Hui Chu,[...]. J Cancer 2021
0


Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advances.
Miralem Mrkonjic, Hal K Berman, Susan J Done, Bruce Youngson, Anna Marie Mulligan. J Clin Pathol 2019
10

Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB.
Samer A Naffouje, Arvind Sabesan, Susan J Hoover, Marie C Lee, Christine Laronga. Ann Surg Oncol 2021
0


The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes.
Lucie Laot, Enora Laas, Noemie Girard, Elise Dumas, Eric Daoud, Beatriz Grandal, Jean-Yves Pierga, Florence Coussy, Youlia Kirova, Elsy El-Alam,[...]. Cancers (Basel) 2021
1


Locoregional therapy in breast cancer patients treated with neoadjuvant chemotherapy.
Sonja Murchison, Pauline Truong. Expert Rev Anticancer Ther 2021
0

Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast Cancer.
Priyanka Sharma, Roisin M Connolly, Evanthia T Roussos Torres, Alastair Thompson. Am Soc Clin Oncol Educ Book 2020
6

Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
Stephanie M Wong, Nora Almana, Jungeun Choi, Jiani Hu, Haley Gagnon, Kelsey Natsuhara, Abra H Shen, Stephen DeSantis, Laura Dominici, Mehra Golshan,[...]. Ann Surg Oncol 2019
25

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.
Yul Ri Chung, Ji Won Woo, Soomin Ahn, Eunyoung Kang, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, Se Hyun Kim, Jee Hyun Kim, So Yeon Park. Sci Rep 2021
0